Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome’s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.
View Top Employees from Noveome Biotherapeutics, Inc.Website | http://www.noveome.com |
Revenue | $7 million |
Funding | $15.3 million |
Employees | 32 (32 on RocketReach) |
Founded | 2000 |
Address | 100 Technology Drive Suite 200, Pittsburgh, Pennsylvania 15221, US |
Phone | (412) 402-9914 |
Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
Category | Biotechnology, Biotechnology Research, Business Services General, Bioscience, Business Services, Science and Engineering, Clinical Trials, Health Care, Life Science |
Web Rank | 5 Million |
Keywords | noveome |
SIC | 873, 87 |
NAICS | 54, 54171, 541714, 541, 5417 |
Looking for a particular Noveome Biotherapeutics, Inc. employee's phone or email?
The Noveome Biotherapeutics, Inc. annual revenue was $7 million in 2023.
Larry Brown is the Executive Vice President and Chief Scientific Officer of Noveome Biotherapeutics, Inc..
32 people are employed at Noveome Biotherapeutics, Inc..
Noveome Biotherapeutics, Inc. is based in Pittsburgh, Pennsylvania.
The NAICS codes for Noveome Biotherapeutics, Inc. are [54, 54171, 541714, 541, 5417].
The SIC codes for Noveome Biotherapeutics, Inc. are [873, 87].